The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDSA.L Regulatory News (RDSA)

  • There is currently no data for RDSA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Royal Dutch Shell Plc

11 Dec 2015 14:20

RNS Number : 8452I
AllianzGI-Global Equity Business
11 December 2015
 

FORM 8.3

 

PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Allianz Global Investors - Global Equity Business Unit

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Royal Dutch Shell Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

10 December 2015

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

Yes - BG Group Plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security:

 

EUR 0.07 A ordinary shares

(incl. A ADRs)

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

43,813,767

1.11%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

16,000

0.00003%

143,000

0.004%

 

TOTAL:

43,829,767

1.11%

143,000

0.004%

 

 

 

 

 

Class of relevant security:

 

EUR 0.07 B ordinary shares

(incl. B ADRs)

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

10,648,511

0.44%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

70,000

0.003%

 

TOTAL:

10,648,511

0.44%

70,000

0.003%

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

EUR 0.07A type ADRs

Sale

58

46.9224

EUR 0.07A type ADRs

Sale

793

46.8831

EUR 0.07A type ADRs

Sale

264

46.8091

EUR 0.07A type ADRs

Sale

118

46.7291

EUR 0.07A type ADRs

Sale

78

46.7031

EUR 0.07A type ADRs

Sale

89

46.7019

EUR 0.07A type ADRs

Sale

745

46.6791

EUR 0.07A type ADRs

Sale

79

46.6192

EUR 0.07A type ADRs

Sale

137

46.6191

EUR 0.07A type ADRs

Sale

150

46.6093

EUR 0.07A type ADRs

Sale

241

46.6091

EUR 0.07A type ADRs

Sale

2,988

46.5664

EUR 0.07A type ADRs

Sale

140

46.5391

EUR 0.07A type ADRs

Sale

190

46.4729

EUR 0.07A type ADRs

Sale

316

46.4254

EUR 0.07A type ADRs

Sale

108

46.4191

EUR 0.07A type ADRs

Sale

541

46.4183

EUR 0.07A type ADRs

Sale

423

46.4115

EUR 0.07A type ADRs

Sale

625

46.3943

EUR 0.07A type ADRs

Sale

58

46.3840

EUR 0.07A type ADRs

Sale

153

46.3741

EUR 0.07A type ADRs

Sale

94

46.3740

EUR 0.07A type ADRs

Sale

184

46.3645

EUR 0.07A type ADRs

Sale

86

46.3635

EUR 0.07A type ADRs

Sale

300

46.3604

EUR 0.07A type ADRs

Sale

148

46.3591

EUR 0.07A type ADRs

Sale

89

46.3542

EUR 0.07A type ADRs

Sale

530

46.3492

EUR 0.07A type ADRs

Sale

107

46.3491

EUR 0.07A type ADRs

Sale

768

46.3482

EUR 0.07A type ADRs

Sale

645

46.3460

EUR 0.07A type ADRs

Sale

727

46.3442

EUR 0.07A type ADRs

Sale

429

46.3435

EUR 0.07A type ADRs

Sale

25

46.3392

EUR 0.07A type ADRs

Sale

128

46.3335

EUR 0.07A type ADRs

Sale

1,043

46.3331

EUR 0.07A type ADRs

Sale

276

46.3327

EUR 0.07A type ADRs

Sale

1,956

46.3314

EUR 0.07A type ADRs

Sale

98

46.3302

EUR 0.07A type ADRs

Sale

408

46.3291

EUR 0.07A type ADRs

Sale

128

46.3241

EUR 0.07A type ADRs

Sale

435

46.3237

EUR 0.07A type ADRs

Sale

128

46.3235

EUR 0.07A type ADRs

Sale

158

46.3228

EUR 0.07A type ADRs

Sale

1,498

46.3205

EUR 0.07A type ADRs

Sale

119

46.3142

EUR 0.07A type ADRs

Sale

66

46.3141

EUR 0.07A type ADRs

Sale

132

46.3136

EUR 0.07A type ADRs

Sale

178

46.3130

EUR 0.07A type ADRs

Sale

148

46.3109

EUR 0.07A type ADRs

Sale

129

46.3093

EUR 0.07A type ADRs

Sale

119

46.2991

EUR 0.07A type ADRs

Sale

143

46.2933

EUR 0.07A type ADRs

Sale

126

46.2932

EUR 0.07A type ADRs

Sale

227

46.2741

EUR 0.07A type ADRs

Sale

50

46.2740

EUR 0.07A type ADRs

Sale

116

46.1594

EUR 0.07A type ADRs

Purchase

341

46.1657

EUR 0.07A type ADRs

Purchase

22

46.1659

EUR 0.07A type ADRs

Purchase

5

46.3160

EUR 0.07A type ADRs

Purchase

257

46.3256

EUR 0.07A type ADRs

Purchase

3,378

46.3257

EUR 0.07A type ADRs

Purchase

86

46.3258

EUR 0.07A type ADRs

Purchase

22

46.3259

EUR 0.07A type ADRs

Purchase

114

46.3361

EUR 0.07A type ADRs

Purchase

1,363

46.3362

EUR 0.07A type ADRs

Purchase

32

46.3363

EUR 0.07A type ADRs

Purchase

14

46.3364

EUR 0.07A type ADRs

Purchase

17

46.3365

EUR 0.07A type ADRs

Purchase

2,685

46.6033

EUR 0.07A type ADRs

Purchase

220

46.8700

EUR 0.07A type ADRs

Purchase

20

46.9300

EUR 0.07A type ADRs

Purchase

215

46.9390

 

 

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

EUR 0.07 A ordinary shares

Sale

221,470

20.6800 EUR

EUR 0.07 A ordinary shares

Purchase

221,470

20.7400 EUR

EUR 0.07 A ordinary shares

Purchase

10,422

21.3626 EUR

EUR 0.07 A ordinary shares

Purchase

55,000

21.5050 EUR

EUR 0.07 A ordinary shares

Purchase

82,530

21.2067 EUR

EUR 0.07 A ordinary shares

Sale

637

21.3109 EUR

EUR 0.07 A ordinary shares

Purchase

23,694

21.4535 EUR

EUR 0.07 B ordinary shares

Purchase

6,987

15.4029 GBP

 

 

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

 

Date of disclosure:

11 December 2015

Contact name:

Sujith Sudevan

Telephone number:

+44 (0) 20 3246 7578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

Identity of person whose open positions are being disclosed:

Allianz Global Investors - Global Equity Business Unit

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Royal Dutch Shell Plc

 

 

 

2. OPTIONS AND DERIVATIVES

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g.American, European etc.

Expiry date

A type shares

Call Option

Written

68,000

EUR 30

American

18 Dec 2015

A type shares

Call Option

Written

75,000

EUR 25.5

American

18 Dec 2015

A type shares

Call Option

Purchased

16,000

EUR 30

American

18 Dec 2015

B type shares

Put Option

Purchased

36,000

GBP 20

American

18 March 2016

B type shares

Put Option

Purchased

34,000

GBP 22

American

18 March 2016

 

 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to contracts for differences ("CFDs") or spread bets.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETGGGAGPUPAGCG
Date   Source Headline
20th Jan 20225:30 pmRNSRoyal Dutch Shell
7th Jan 20226:00 pmRNSRoyal Dutch Shell
30th Nov 20204:37 pmRNSPrice Monitoring Extension
27th Mar 20204:43 pmRNSSecond Price Monitoring Extn
27th Mar 20204:39 pmRNSPrice Monitoring Extension
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:06 pmRNSPrice Monitoring Extension
13th Mar 20204:43 pmRNSSecond Price Monitoring Extn
13th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20204:43 pmRNSSecond Price Monitoring Extn
12th Mar 20204:38 pmRNSPrice Monitoring Extension
24th Oct 20195:19 pmPRNPublication of Prospectus
17th Oct 20195:18 pmPRNTransaction in Own Shares
16th Oct 20195:51 pmPRNTransaction in Own Shares
15th Oct 20195:14 pmPRNTransaction in Own Shares
14th Oct 20195:35 pmPRNTransaction in Own Shares
11th Oct 20195:39 pmPRNTransaction in Own Shares
10th Oct 20195:20 pmPRNTransaction in Own Shares
9th Oct 20195:30 pmPRNTransaction in Own Shares
8th Oct 20195:34 pmPRNTransaction in Own Shares
7th Oct 20195:23 pmPRNTransaction in Own Shares
4th Oct 20195:28 pmPRNTransaction in Own Shares
3rd Oct 20195:37 pmPRNTransaction in Own Shares
2nd Oct 20195:37 pmPRNTransaction in Own Shares
1st Oct 20195:37 pmPRNTransaction in Own Shares
30th Sep 20195:47 pmPRNTransaction in Own Shares
30th Sep 20193:05 pmPRNVoting Rights and Capital
30th Sep 20197:00 amPRNShell enhances quarterly disclosures
27th Sep 20195:06 pmPRNTransaction in Own Shares
26th Sep 20195:39 pmPRNDirector/PDMR Shareholding
26th Sep 20195:33 pmPRNTransaction in Own Shares
26th Sep 20194:16 pmPRNDirector/PDMR Shareholding
25th Sep 20195:41 pmPRNTransaction in Own Shares
24th Sep 20195:39 pmPRNTransaction in Own Shares
23rd Sep 20195:24 pmPRNTransaction in Own Shares
20th Sep 20195:16 pmPRNTransaction in Own Shares
19th Sep 20194:59 pmPRNTransaction in Own Shares
18th Sep 20195:21 pmPRNTransaction in Own Shares
17th Sep 20195:01 pmPRNTransaction in Own Shares
16th Sep 20195:16 pmPRNTransaction in Own Shares
13th Sep 20195:03 pmPRNTransaction in Own Shares
12th Sep 20195:15 pmPRNTransaction in Own Shares
11th Sep 20195:08 pmPRNTransaction in Own Shares
10th Sep 20195:13 pmPRNTransaction in Own Shares
9th Sep 20195:17 pmPRNTransaction in Own Shares
9th Sep 20194:34 pmPRNSecond Quarter 2019 EUR GBP Equivalent Dividend Payments
6th Sep 20196:02 pmPRNTransaction in Own Shares
5th Sep 20195:09 pmPRNTransaction in Own Shares
4th Sep 20195:18 pmPRNTransaction in Own Shares
3rd Sep 20195:29 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.